GMP – Page 95 – Pharma.Tips

Change control documentation gaps during post-approval change review – inspection questions regulators ask

Addressing Gaps in Change Control Documentation for Post-Approval Reviews Change control in pharmaceutical manufacturing plays a crucial role in ensuring compliance and quality throughout the product lifecycle. However, gaps in…

Supplier audit findings escalated during supplier onboarding – inspection questions regulators ask

Investigating Escalated Supplier Audit Findings During Onboarding In pharmaceutical manufacturing, effective vendor qualification and supplier audits are critical components in maintaining quality and compliance. However, supplier audit findings can sometimes…

Unapproved material substitution during deviation investigation – CAPA to prevent repeat failures

Addressing Unapproved Material Substitution in Deviation Investigations: A Comprehensive Playbook In the fast-paced environment of pharmaceutical manufacturing, instances of raw material substitution can occur, sometimes leading to serious deviations from…

Supplier audit findings escalated during supplier onboarding – how to prevent repeat supplier failures

Addressing Supplier Audit Failures During Onboarding: An Investigative Approach In the realm of pharmaceutical manufacturing, timely and compliant supplier evaluations are essential to maintaining product quality and safety. However, instances…

Specification change not communicated during supplier change – risk-based change impact assessment

Playbook for Addressing Uncommunicated Specification Changes During Supplier Transitions In the pharmaceutical manufacturing landscape, maintaining raw material consistency is vital to ensuring product quality and regulatory compliance. A scenario that…

Inadequate vendor qualification during supply disruption – audit CAPA remediation framework

Addressing Inadequate Vendor Qualification during Supply Disruption: An Audit CAPA Remediation Framework In the pharmaceutical landscape, inadequate vendor qualification can have significant implications, especially during supply disruptions. Such scenarios often…

Change impact underestimated during routine operations – preventing batch rejection and recalls

Understanding and Managing Change Impact During Routine Operations to Prevent Batch Rejection and Recalls In the pharmaceutical manufacturing sector, underestimating change impact during routine operations can lead to significant risks,…

Vendor change implemented without approval during regulatory inspection – inspection questions regulators ask

Investigation of Unapproved Vendor Changes During Regulatory Inspections In the complex landscape of pharmaceutical manufacturing, unexpected vendor changes can have significant consequences, especially when such alterations occur without the necessary…

Specification change not communicated during routine operations – regulatory expectations for material changes

Actionable Guidance on Addressing Uncommunicated Specification Changes in Routine Operations In the highly regulated pharmaceutical landscape, uncommunicated changes to raw material specifications during routine operations can pose significant risks. These…

Audit response ineffective during routine supplier audit – audit CAPA remediation framework

Framework for Addressing Ineffective Audit Responses During Supplier Assessments In a fast-paced pharmaceutical environment, the integrity of raw materials directly influences product quality, regulatory compliance, and operational efficiency. An ineffective…

Supplier change not evaluated during post-approval change review – preventing batch rejection and recalls

Mitigating Risks of Unassessed Supplier Changes in Post-Approval Review Processes In the pharmaceutical industry, the integrity of raw materials is paramount to ensuring the quality of the final product. However,…

Supplier audit findings escalated during routine supplier audit – inspection questions regulators ask

Investigating Supplier Audit Findings Escalated During Routine Supplier Audits During routine supplier audits, findings may surface that escalate concerns regarding raw material quality and compliance. Understanding how to effectively investigate…